RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Cash from investing

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Jun 30, 2025-200-25.85%
Jun 30, 2024-270-76.74%
Jun 30, 2023-1,160+404.46%
Jun 30, 2022-230+45.09%
Jun 30, 2021-158-11.90%
Jun 30, 2020-180-83.28%
Jun 30, 2019-1,076+956.44%
Jun 30, 2018-102+24.34%
Jun 30, 2017-82-92.73%
Jun 30, 2016-1,126+686.85%
Jun 30, 2015-143+50.62%
Jun 30, 2014-95+21.78%
Jun 30, 2013-78-23.24%
Jun 30, 2012-102+32.81%
Jun 30, 2011-77

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)